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Abstract. 
 
Immunoglobulin heavy chain-binding pro-
tein (BiP) is a member of the hsp70 family of chaper-
ones and one of the most abundant proteins in the ER 
lumen. It is known to interact transiently with many na-
scent proteins as they enter the ER and more stably 
with protein subunits produced in stoichiometric excess 
or with mutant proteins. However, there also exists a 
large number of secretory pathway proteins that do not 
apparently interact with BiP. To begin to understand 
what controls the likelihood that a nascent protein en-
tering the ER will associate with BiP, we have exam-
ined the in vivo folding of a murine 
 
l
 
I immunoglobulin 
(Ig) light chain (LC). This LC is composed of two Ig 
domains that can fold independent of the other and 
that each possess multiple potential BiP-binding se-
quences. To detect BiP binding to the LC during fold-
ing, we used BiP ATPase mutants, which bind irrevers-
ibly to proteins, as Òkinetic traps.Ó Although both the 
wild-type and mutant BiP clearly associated with the 
unoxidized variable region domain, we were unable to 
detect binding of either BiP protein to the constant re-
gion domain. A combination of in vivo and in vitro 
folding studies revealed that the constant domain folds 
rapidly and stably even in the absence of an intrado-
main disulfide bond. Thus, the simple presence of a 
BiP-binding site on a nascent chain does not ensure 
that BiP will bind and play a role in its folding. Instead, 
it appears that the rate and stability of protein folding 
determines whether or not a particular site is recog-
nized, with BiP preferentially binding to proteins that 
fold slowly or somewhat unstably.
Key words: BiP ¥ endoplasmic reticulum ¥ chaperone ¥ 
protein folding
 
P
 
ROTEINS
 
 that traverse the mammalian secretory path-
way are translated on polyribosomes attached to
the endoplasmic reticulum (ER) membrane (Walter
and Johnson, 1994). This allows cotranslational transloca-
tion of the nascent chain into the ER as an extended or un-
folded polypeptide. Upon entering the lumen of the ER,
the nascent protein encounters a variety of molecular
chaperones and folding enzymes and begins to fold, in
some cases, even before translation is complete (Ham-
mond et al., 1994). One of the molecular chaperones
encountered by newly synthesized polypeptides is BiP/
GRP78, the ER cognate of the hsp70 family (Haas, 1991;
Gething and Sambrook, 1992). In yeast, immunoglobulin
heavy chain-binding protein (BiP)
 
1
 
 is required for translo-
cation and may act to pull the nascent chain into the ER
through cycles of binding and release (Vogel et al., 1990).
Mammalian BiP is present at the translocon where it serves
to maintain the permeability barrier of the ER during the
early stages of targeting nascent chains into the translocon
(Hamman et al., 1998). However, there is no clear evi-
dence that mammalian BiP plays a direct role in pulling
proteins into the ER, and this point remains unresolved
(Gorlich and Rapoport, 1993; Nicchitta and Blobel, 1993).
BiP, like all hsp70 family members, binds to unfolded
nascent polypeptides (Landry et al., 1992; Simons et al.,
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1. 
 
Abbreviations used in this paper: 
 
2-ME, 2-mercaptoethanol; BiP, immu-
noglobulin heavy chain-binding protein; C, constant; C
 
H
 
1, first constant
domain of the heavy chain; C
 
L
 
, single constant domain of the light chain;
cWT
 
l
 
, pSV
 
l 
 
eukaryotic expression vector; ER-C
 
l
 
, a 
 
l
 
1 constant domain
that could be translocated to the ER lumen; gWT
 
l
 
, pJDE
 
lI 
 
genomic
clone; LC, light chain; V, variable; WT, wild-type. 
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1995; Hendershot et al., 1996), although exactly what BiP
recognizes on a newly synthesized protein and how this
binding contributes to protein folding in not clearly under-
stood. Several in vitro (Munro and Pelham, 1986; Hen-
drick and Hartl, 1993; Palleros et al., 1993) and in vivo
(Hendershot et al., 1995; Simons et al., 1995) studies dem-
onstrated that hsp70 release and polypeptide folding are
dependent on ATP binding to hsp70. In vitro peptide-
binding studies revealed that BiP recognizes heptapep-
tides and prefers those with aliphatic residues (Flynn et al.,
1991). Flynn et al. (1991) speculated that sequences of this
type would appear approximately every 16 residues in the
average globular protein. A somewhat similar recognition
motif was identified when purified BiP was used to affinity
pan a library of peptides displayed on bacteriophages
(Blond-Elguindi et al., 1993). Further analysis of these
peptides revealed that the aliphatic residues were pre-
ferred only for alternating residues, suggesting that if a
protein containing this sequence was extended, the hydro-
phobic residues would all face the same direction and per-
haps fit in to the BiP polypeptide-binding pocket (Blond-
Elguindi et al., 1993). Although sequences of this type can
indeed be found in most proteins entering the ER, it ap-
pears that some secretory pathway proteins do not nor-
mally bind to BiP (Hurtley et al., 1989; Graham et al.,
1990; Morris et al., 1997). This is perplexing if these pro-
teins are entering the ER in an extended conformation
and BiP, which is present at the translocon at least initially
(Hamman et al., 1998), ÒscansÓ nascent chains as they en-
ter the ER. It is possible that for some proteins BiP bind-
ing is very transient and limited to chains that are not fully
translated, or conversely that the presence of a potential
BiP-binding sequence does not in itself dictate whether
BiP will bind.
The algorithm generated by phage display analysis to
identify BiP binding sites (Blond-Elguindi et al., 1993) has
been applied to immunoglobulin (Ig) domain sequences
(Knarr et al., 1995). As predicted by Flynn et al. (1991),
multiple ÒBiP-binding sitesÓ were identified in both the
variable and constant region domains of the heavy and
light chains subjected to this analysis. Peptides corre-
sponding to these sequences were generated and shown to
stimulate the ATPase activity of BiP (Knarr et al., 1995),
which is presumed to be an indication of their binding to
the protein-binding domain of BiP. It is unclear which, if
any, of these sites are used in vivo and how BiP binding to
various Òhydrophobic sequencesÓ might be regulated dur-
ing translocation and folding.
Ig heavy and light chains are comprised of a series of
tandemly aligned Ig domains (four or five and two, respec-
tively) that can fold independent of each other in vitro
(Goto et al., 1979; Goto and Hamaguchi, 1982) into a com-
pact structure composed of two twisted 
 
b
 
 sheets stabilized
by a single disulfide bond (Amzel and Poljak, 1979). Ig
LCs bind transiently to BiP and can be secreted without
heavy chains, making them a relatively simple protein for
in vivo folding analyses. In a recent study, we coexpressed
murine 
 
l 
 
light chain
 
 
 
(LC) in COS cells together with ei-
ther wild-type hamster BiP or BiP ATPase mutants that
bind substrate proteins but do not release them (Wei et al.,
1995). The LCs were synthesized in the presence of dithio-
threitol (DTT), which is a fully reversible reducing agent
in vivo (Braakman et al., 1992a,b). This treatment pre-
vents LC oxidation and maximizes the binding of LCs to
both wild-type and mutant BiP. Removing the DTT, al-
lows LCs expressed with wild-type BiP to fold and form
intradomain disulfide bonds in both domains, whereas
those coexpressed with mutant BiP were only capable of
oxidizing a single domain (Hendershot et al., 1996). In
spite of the structural similarity between the variable (V)
and constant (C) domain of the LC and the prediction of
multiple BiP-binding sites per Ig domain, these data argue
that only a single LC domain binds to BiP in vivo. This
suggests that either the algorithm is not a good detector of
BiP-binding sites or that these two domains have different
requirements for folding in vivo, and that the simple pres-
ence of a BiP-binding sequence does not ensure that it will
be used.
In the present study, we confirmed that BiP binds to a
single 
 
l
 
 LC domain in vivo and determined which one it is.
Then using a combination of in vivo and in vitro BiP-bind-
ing and protein-folding assays, we examined the reason for
the differential association of BiP with these domains in
the ER.
 
Materials and Methods
 
Construction of 
 
l
 
I LC Mutants
 
Before producing LC cysteine mutants, it was necessary to obtain a cDNA
clone of the 
 
l
 
I LC gene. The pJDE
 
l
 
I genomic clone (gWT
 
l
 
) originally
obtained from the murine myeloma HOPC 2020 (Bernard et al., 1978)
and provided by Dr. Y. Argon (University of Chicago, Chicago, IL) was
transiently expressed in COS 1 cells. RNA was isolated (RNAzol B; Tel-
Test) and 
 
l
 
-specific mRNA was amplified by reverse transcription PCR
using (CTGACCAATCTAGAAAAGAATAG) as the 5
 
9 
 
primer and
(CCTCTGTGGATCCAATGAAGGTT) as a 3
 
9
 
 primer. The PCR prod-
uct was digested with XbaI and BamHI and ligated into the pTZ vector.
The entire cDNA clone was sequenced before recloning it into the pSVL
eukaryotic expression vector (cWT
 
l
 
) for use in transfection studies.
The variable region cysteines (C
 
41
 
 and C
 
109
 
) and constant region cys-
teines (C
 
156
 
 and C
 
215
 
) responsible for forming the intradomain disulfide
bonds were mutated to serine by overlap extension PCR as described (Ho
et al., 1989). The final PCR products were digested with XbaI and BbsI
(V
 
mut
 
) or BbsI and BamHI (C
 
mut
 
) and inserted into pTZ-cWT
 
l
 
 in place of
the corresponding wild-type sequence. The alterations of the cysteine res-
idues to serine and the absence of other mutations were verified by DNA
sequencing before the mutants were subcloned into the pSVL vector.
An ER-targeted constant region domain was created by removing 107
amino acids (Val
 
22
 
ÐLeu
 
128
 
) which encode the variable region of the 
 
l
 
I LC.
Oligonucleotides were designed to give a PCR product that joined the se-
quence encoding Ala
 
21
 
 (the second amino acid of the mature variable re-
gion) to Gly
 
129
 
 (the first amino acid of the constant region). The resulting
cDNA (ER-C
 
l
 
) encodes a protein with the ER-targeting signal sequence,
the first two amino acids of the variable domain (to ensure proper cleav-
age of the signal sequence after translocation), and the entire constant re-
gion domain. The cDNA product was sequenced to verify the deletion
and to ensure the constant region was not altered before inserting it into
pSVL, a eukaryotic expression vector.
 
Construction of Recombinant Variable and
Constant Domains
 
For in vitro protein folding studies, individual domains were produced in
bacteria and purified using the 6
 
3 
 
histidine tag methodology (QIAGEN).
A BamHI site followed by a factor Xa site (Ile-Glu-Gly-Arg) was intro-
duced immediately 5
 
9
 
 of the sequence encoding the NH
 
2
 
 terminus of the
mature variable domain (Glu
 
20
 
) or the NH
 
2
 
 terminus of the constant do-
main (Gly
 
129
 
). Additionally, a stop codon was inserted at the end of the
variable region coding sequence (Leu
 
128
 
). Each modified domain was
excised and ligated into the QE-10 vector for expression in bacteria 
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cells. The final coding sequence for the variable domain was MRGS-
HHHHHHTDPIEGRQ
 
20
 
ÐL
 
128
 
 and for the constant domain MRGSHH-
HHHHTDPIEGRG
 
129
 
ÐS
 
234
 
. This construction allowed for purification on
Ni
 
2
 
1
 
-agarose columns and would allow us, if necessary, to cleave the tag
with factor Xa leaving an intact Ig domain.
 
Recombinant Protein Isolation
 
Bacteria transformed with the individual Ig domains were grown to an
OD
 
595
 
 of 0.7 and protein expression was induced for 2 h with 1 mM IPTG.
Initial experiments showed that neither construct (particularly the vari-
able domain) gave high yields of soluble protein when the standard isola-
tion protocol was followed (Wei and Hendershot, 1995). In an attempt to
increase the yield of soluble protein, the bacterial pellets were resus-
pended in 16 ml (5 ml/g of bacteria) of buffer A (0.1 M NaH
 
2
 
PO
 
4
 
, 0.01 M
Hepes, 6 M GdmCl, pH 8) containing 1 mM DTT. The cell lysate was
stirred at room temperature for 40 min and then 10 mM 2-mercaptoetha-
nol (2-ME) was added and the sample was stirred for an addition 20 min.
The lysate was sonicated and centrifuged at 10,000 rpm. Batch adsorption
was performed by adding 1 ml Ni-NTA-agarose (QIAGEN) equilibrated
in buffer A containing 10 mM 2-ME to the supernatant. The sample was
stirred for 90 min at room temperature and loaded into a polypropylene
disposable column. The resin was extensively washed with buffer A con-
taining 2-ME, and the bound protein was allowed to refold on the column
through successive washes with the following solutions: (a) buffer B (0.1 M
NaH
 
2
 
PO
 
4
 
, 0.01 M Hepes, 0.5 M NaCl, pH 7.5) containing 3 M GdmCl and
10 mM 2-ME; (b) buffer B containing 1 M GdmCl and 3 mM 2-ME; (c)
buffer B containing 0.3 M GdmCl and 1 mM 2-ME; (d) buffer B; (e)
buffer B containing 10% (vol/vol) glycerol. Proteins were eluted with 2 ml
of buffer B containing 10% glycerol and 250 mM imidazole. The sample
was loaded on a 5-ml polyacrylamide desalting column (Pierce) equili-
brated with 20 mM Hepes, 300 mM NaCl, 10% glycerol, pH 7.5, to re-
move the imidazole.
 
Thermal Unfolding Curves
 
Thermal unfolding curves were obtained for recombinant BiP and for
DTT-reduced C domain and analyzed as described (Vanhove et al., 1995).
The experiments were performed in 20 mM Hepes, pH 7.5, 300 mM NaCl,
10% glycerol, 10 mM DTT. Protein concentrations were 2 
 
m
 
M for the C
domain and 4 
 
m
 
M for BiP, and temperature was increased at a rate of 1
 
8
 
C/
min. Unfolding of the protein was monitored by fluorescence spectros-
copy and data are presented as the fraction of native protein remaining at
each temperature.
 
BiP Score Algorithm
 
Potential BiP-binding sites on the V and C domain were identified by a
computer algorithm we developed using the BiP-binding scores deter-
mined by Blond-Elguindi et al. (1993). These scores reflected the proba-
bility of finding particular amino acids at specific positions within octo-
meric peptides that bound to BiP. For each of the 20 amino acids,
numerical scores ranging from negative to positive values were assigned
based on the likelihood that the amino acid was excluded or included at
positions 1Ð8 in BiP-binding peptides. The LC sequence was analyzed
eight amino acids at a time, and the algorithm determined scores associ-
ated with each overlapping octomer and reported the values on a position
by position basis. This provided an indication of the propensity of the fol-
lowing octomer to interact with BiP.
 
COS Transfections
 
For in vivo analysis of BiP binding to the various 
 
l
 
I LC mutants, COS-1
cells were cotransfected with the various 
 
l
 
 constructs along with cDNAs
for either wild-type (WT) hamster BiP (obtained from A.S. Lee, Univer-
sity of Southern California, Los Angeles, CA) or a BiP ATPase mutant
created by changing Thr
 
37
 
 to Gly
 
37
 
 (G37) (Gaut and Hendershot, 1993;
Wei et al., 1995) as described previously (Hendershot et al., 1995). In all
cases, the transfected cells were analyzed 40 h after transfection, but the
constructs and labeling conditions varied for the individual experiments
and are detailed in the results section and figure legends. Transfected cells
were biosynthetically labeled with [
 
35
 
S] Translabel (ICN). For pulseÐchase
experiments, cells were preincubated in met
 
2
 
Ðcys
 
2
 
 labeling media for 45
min before the isotope was added. When labeled proteins were analyzed
under nonreducing conditions, cells were washed first with PBS contain-
ing 20 mM NEM before lysing. NEM and apyrase were included in the
lysing buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.5% DOC, and 0.5%
NP-40). Labeled lysates were reacted with a polyclonal rabbit antiÐrodent
BiP antiserum (Hendershot et al., 1995) or with a polyclonal goat antiÐ
mouse 
 
l
 
 antiserum (Southern Biotechnology), and immune complexes
were precipitated by binding to protein AÐSepharose beads. Proteins
were resolved on SDS-polyacrylamide gels under either reducing or non-
reducing conditions and visualized by fluorography using the Amplify re-
agent (Amersham).
 
Results
 
BiP ATPase Mutants Block Folding of Only One
 
l 
 
LC Domain
 
Previous studies using a genomic 
 
l
 
I LC clone suggested
that only a single LC domain binds to BiP and is unable to
fold in the presence of BiP ATPase mutants (Hendershot
et al., 1996). As a first step toward identifying the domain
that BiP binds, we produced a 
 
l
 
I LC cDNA clone (cWT
 
l
 
)
that would serve as a template for producing LC domain
mutants. This construct was transiently coexpressed with
either wild-type hamster BiP or a BiP ATPase mutant,
G37, which binds stably to target proteins in vivo (Wei et al.,
1995). As was observed with the genomic clone, the cDNA
produced a 
 
l
 
 LC that was expressed at high levels and
bound to both wild-type and mutant BiP when synthesized
under reducing conditions (Fig. 1). Subsequent removal of
DTT allows the formation of disulfide bonds in both do-
mains, which is dependent on LC folding to bring the in-
tradomain cysteine residues into the correct position
(Goto and Hamaguchi, 1981). This oxidation causes an in-
crease in the mobility of the protein that, unlike protein
folding itself, can be monitored on SDS-polyacrylamide
gels (Braakman et al., 1992a; Hendershot et al., 1996).
When DTT was removed, the LC expressed with wild-type
BiP folded completely and disulfide bonds were formed in
both domains (Fig. 1). When LCs coexpressed with mu-
tant BiP were analyzed similarly, approximately half of the
LCs underwent complete folding and oxidation. This is
presumably due to the fact that the endogenous wild-type
BiP present in these cells competes with the mutant BiP
for binding to the reduced LCs (Hendershot et al., 1996).
When DTT is removed, those LC bound to the endoge-
nous BiP are capable of folding completely. The other half
of the LC (i.e., those bound to the mutant BiP), underwent
Figure 1. Characterization of
lI LC cDNA clone. COS-1
cells were transfected with
the wild-type l cDNA clone
along with either wild-type
or ATPase mutant (G37)
hamster BiP. Cells were met-
abolically labeled in the pres-
ence of 10 mM DTT for 30
min and then chase for 0 or
1 h in complete media with-
out DTT. Labeled lysates
were immunoprecipitated with
anti-l antiserum and ana-
lyzed on nonreducing SDS-
polyacrylamide gels. 
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partial folding and oxidization as determined by their in-
termediate mobility. If both domains contained BiP-bind-
ing sites that could be used simultaneously, a portion of
the LC should have remained completely reduced. Thus, it
appears that either a single domain expresses BiP-binding
sites or that only a single domain can bind to BiP at a time.
 
Production of LC Domain Mutants That Lack Cysteine 
Residues Required for Intrachain Disulfide Bonds
 
To determine which LC domain was bound to BiP and un-
able to fold in the presence of BiP mutants, we mutated
the cysteine pairs that form the intradomain disulfide
bond to serine in each of the domains separately. Both 
 
l
 
LC mutants were transiently expressed in COS cells and
the resultant LC proteins were compared with wild-type 
 
l
 
LC. On reducing gels, the V and C domain mutants mi-
grated exactly the same as wild-type LC produced from ei-
ther the genomic (gWT
 
l
 
) or cDNA (cWT
 
l
 
) clone (Fig. 2).
These labeled LCs were also analyzed under nonreducing
conditions to determine their oxidation status. During the
final 10 min of biosynthetic labeling, DTT was added to a
dish transfected with cWT
 
l
 
 in order to produce a mixture
of completely reduced (F
 
0
 
), partially oxidized (F
 
1
 
), and
completely oxidized (F
 
ox
 
) intermediates of 
 
l
 
 LC for com-
parison. The genomic and cDNA clones of wild-type 
 
l
 
produced completely oxidized LC that comigrated with
the fastest migrating band in the DTT-treated sample (Fig.
2). Both the V and C domain cysteine mutants migrated
with an intermediate mobility (F
 
1
 
), which was expected if
one domain folded and formed an intradomain disulfide
bond but the other did not. This demonstrated that muta-
tion of the cysteines prevented disulfide bond formation in
the targeted domain but did not alter folding and disulfide
bond formation in the nonmutated domain.
We examined the effects of genetically interrupting di-
sulfide bond formation on secretion of the two LC mu-
tants. Under labeling conditions where the wild-type LC
was readily secreted, we observed no secretion of either
the V
 
mut
 
l
 
 or the C
 
mut
 
l
 
 (Fig. 3). Thus, disulfide bond for-
mation in both domains is required for LC secretion. All
LC possess a COOH-terminal cysteine that remains un-
paired in LCs that have not formed homodimers or assem-
Figure 2. Characterization of V and C region in-
tradomain cysteine mutants. COS-1 cells were
transfected with genomic (gWTl) or cDNA
(cWTl, cVmutl, and cCmutl) LC expression vec-
tors. Cells were pulse labeled for 30 min, lysed
in the presence of 20 mM NEM, immunopre-
cipitated with anti-l antiserum, and then ana-
lyzed on either reducing or nonreducing SDS-
polyacrylamide gels. A plate transfected with
cWTl had DTT added for the last 10 min of the
30 min label. This sample serves as a control on
the nonreduced gel for the migration of reduced
(F0), partially oxidized (F1), and fully oxidized
(Fox) l LCs.
Figure 3. Neither the V or C domain mutants are transport com-
petent. COS-1 cells were transfected with the cDNA clones for
WTl, Vmutl, and Cmutl. Cells were metabolically labeled for 3 h.
Culture supernatants were saved and immunoprecipitated with
anti-l (lm), and lysates were prepared, divided, and then immu-
noprecipitated with either anti-l followed by protein AÐSeph-
arose (l) or protein AÐSepharose (P.A.) alone (to control for
nonspecific binding). Samples were analyzed on SDS gels under
reducing conditions. 
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bled with heavy chains. To determine if a thiol-mediated
retention mechanism (Alberini et al., 1990; Fra et al.,
1993) was responsible for the lack of secretion, we treated
cells with 2-
 
b
 
 mercaptoethanol. This did not induce the se-
cretion of either LC mutant (data not shown), suggesting
that the thiol-mediated retention system (Alberini et al.,
1990; Fra et al., 1993) is not solely responsible for keeping
these LCs in the cell.
 
Expression of a BiP ATPase Mutant Had No Additional 
Effect on the Folding of the 
 
l 
 
V
 
mut
 
, Whereas It Further 
Inhibited the Folding of 
 
l
 
 C
 
mut
 
If BiP binds to a single LC domain, expression of the BiP
ATPase mutant should only further affect oxidation of the
LC mutant that had cysteine changes in the nonÐBiP-bind-
ing domain. Conversely, if both domains were capable of
binding to BiP but only one BiP molecule could bind to
the LC at a time, the mutant BiP should either further pre-
vent the oxidation (i.e., from F
 
1
 
 to F
 
0
 
) of both LC mutants
or have no further effect on either, depending on whether
BiP was already associated with the nondisulfide-bonded
domains. Either way, BiP mutant expression should affect
both domains equally. Wild-type 
 
l
 
 and both l mutants
were coexpressed with either wild-type or G37 mutant
BiP. Transfected cells were pulse labeled with [35S]me-
thionine and [35S]cysteine in the presence of DTT to in-
hibit disulfide bond formation and then chased in the ab-
sence of DTT to allow the LC domains to fold and form
disulfide bonds. As in previous experiments, wild-type l
LCs were oxidized completely during the 1-h chase when
expressed with wild-type BiP, but about half of the LC ex-
pressed with mutant BiP failed to be oxidized completely
as evidenced by the presence of the F1 form of the LC
(Fig. 4). There is some variability in the percentage of LC
in the F1 and Fox forms between experiments, which may
relate to the relative pool size of transfected mutant BiP
and endogenous WT BiP. The Vmutl migrated with an in-
termediate mobility (F1) when coexpressed with wild-type
BiP. This was anticipated because the V region cannot
form a disulfide bond due to mutation of its cysteine resi-
dues, and the other domain was shown to fold indepen-
dently when synthesized in the absence of DTT (Fig. 2).
Coexpression of the BiP ATPase mutant with Vmutl did
not significantly inhibit the LC from forming the F1 inter-
mediate. When the Cmutl was analyzed in the same way,
we found that in the presence of wild-type BiP, it oxidized
to the F1 intermediate after 1 h of chase, although not as
efficiently as either the wild-type l LC or the Vmutl (Fig. 4).
However, when the Cmutl was coexpressed with the BiP
ATPase mutant it was almost completely inhibited in its
ability to form the F1 intermediate indicating that in the ab-
sence of BiP release both the VL and CL domain remained
unoxidized. This strongly suggests that BiP binds to only a
single domain in the l LC and that it is the V domain.
There are several other interesting observations in this
experiment. First, the wild-type and Vmut LC appear to be
more resistant to DTT-mediated reduction than the Cmut,
because in the pulse material (0) a portion of both these
LC are partially oxidized (F1 form). Since the oxidized do-
main in the Vmut can only be the constant region domain,
this suggests that the C domain is more resistant to reduc-
tion. In keeping with this, when the C domain cannot form
disulfide bonds (Cmut), the V domain is readily reduced
(i.e., no evidence of a partially oxidized, F1 form). Thus, al-
though the folded tertiary structure is very similar for both
domains, their ability to bind BiP and the susceptibility of
their disulfide bonds to reducing agents are not the same.
Previous studies have shown that buried disulfide bonds in
Ig domains are fairly resistant to reducing agents. Thus, it
is reasonable to suggest that during biosynthesis the C do-
main is folding and burying its disulfide bond so rapidly
that a portion of it is resistant to DTT. The second inter-
esting finding is that coexpression of mutant BiP dimin-
ished the post-DTT recovery of both wild-type and Cmut
LC but did not greatly change the amount of Vmut LC (Fig.
4). The significance of this observation is not clear but may
relate to the fact that mutant BiP expression would ad-
versely affect the folding of both wild-type and Cmut LC by
preventing the oxidation of the V domain. However, irre-
Figure 4. Mutant BiP expression further inhibits
folding of the C domain mutant but has not fur-
ther effect on the folding of the V domain mu-
tant. COS-1 cells were cotransfected with one of
the l LC cDNA clones (WTl, Vmutl, or Cmutl)
and either wild-type (WT) or mutant (G37) BiP.
Transfected cells were incubated in met2Ðcys2
media for 45 min, pulse labeled for 45 min in the
presence of 10 mM DTT, and then chased for 0
or 1 h in complete media without DTT. Cells
were lysed in buffer containing 20 mM NEM and
10 U apyrase. Labeled proteins were immuno-
precipitated with anti-l and analyzed under non-
reducing conditions. Again, a plate transfected
with WTl had DTT added for the final 10 min of
labeling to serve as a control for the mobility of
the various LC folding intermediates (WTl  1
DTT).The Journal of Cell Biology, Volume 144, 1999 26
versible binding of the BiP mutant to the V domain would
not have any further affect on the Vmut, because this do-
main was already unable to fold.
BiP Only Binds to the V domain of the l LC In Vivo
The data in the previous experiment strongly suggest that
BiP binds to the unoxidized variable region domain but
does not associate with the unoxidized constant region do-
main. To examine this directly, both Vmut and Cmut LCs
were coexpressed with wild-type BiP. Transfected cells
were metabolically labeled in the presence of DTT and
then chased without DTT. Lysates were immunoprecipi-
tated with antibodies specific for l LC and for rodent BiP.
Immediately after labeling (0 chase), both the unfolded
Vmut and Cmut LCs were coprecipitated with BiP (Fig. 5).
After a 1-h chase, a portion of the Vmut had folded to the
F1 intermediate. Both this intermediate and the com-
pletely reduced (F0) form bound to BiP and could be
coprecipitated with the anti-BiP antiserum. Interestingly,
BiP appeared to bind better to the completely reduced
form than to the partially oxidized LC, as suggested by the
fact that a larger proportion of the F0 form was coprecipi-
tated with BiP than the F1 form. Although we do not un-
derstand the reason for this difference, it is possible that if
BiP binds to V region sequences that are close to the C do-
main, folding and oxidation of the C domain could some-
how weaken this interaction and make it less stable during
immunoprecipitation. Examination of the Cmut LC re-
vealed that although half of the LC achieved the F1 folding
intermediate, they did not bind to BiP. Only the com-
pletely reduced (F0) form (in which the V domain was also
unoxidized) was capable of associating with BiP (Fig. 5).
Thus, BiP only binds to the unoxidized V domain of the
full-length LC in vivo.
ER-targeted C Domain Does Not Associate with BiP
It is possible that because the V domain enters the ER
first, BiP binds to this domain, and then sterically hinders
a second BiP molecule from binding to the C domain as it
enters. To examine this possibility, we produced a lI con-
stant domain that could be translocated into the ER lumen
(ER-Cl) by engineering the cleavable ER signal sequence
from the original full-length l LC (Bernard et al., 1978)
onto the NH2 terminus of the C domain. Both full-length
wild-type l LC and the ER-directed C domain were tran-
siently expressed in COS cells. Metabolic labeling re-
vealed that similar to WTl LC, the ER-Cl was synthe-
sized and secreted from the transfected cells (Fig. 6 A).
This demonstrated that, not only did the signal sequence
target this domain to the ER, but that the signal sequence
was efficiently cleaved and the isolated C domain was
transport competent. Under steady-state labeling, some
BiP was coprecipitated with wild-type l LC and vice versa.
However, when the C domain was analyzed in the same
way, there was no evidence of BiP coprecipitating with the
C domain or of the C domain coprecipitating with BiP
(Fig. 6 A).
Steady-state labeling is not the most sensitive way to de-
tect BiP association with proteins because the interactions
are often transient or unstable. Therefore, we reexamined
the ability of the isolated C domain to associate with BiP
by coexpressing it with either wild-type or mutant BiP and
pulse labeling under reducing conditions to inhibit folding
of the domain. Under these conditions, the WTl LC was
easily detected in association with BiP (Fig. 6 B). Con-
versely, even under the most sensitive conditions for dem-
onstrating BiP association with target proteins, there was
no detectable evidence for BiP interacting with the ER-Cl
in vivo.
BiP-binding Sites Are Predicted to Occur in Both the V 
and C Domain of the lI LC
Our inability to detect BiP complexed to the C domain by
any of the methods described above could mean the C do-
main does not possess BiP-binding sites. Alternatively, po-
tential BiP-binding sites might be present but the C do-
main could fold too rapidly and stably, even in the absence
of disulfide bond formation, to express them. A BiP-bind-
Figure 5. BiP binds to the unoxidized V domain
but not to the unoxidized C domain. COS-1 cells
were transfected, labeled, and then lysed as in
Fig. 4. Lysates from both the 0- and 1-h chase
were divided and immunoprecipitated with ei-
ther a polyclonal anti-rodent BiP antiserum or
anti-mouse l. The WTl with partial DTT treat-
ment is include in the middle of the gel as a con-
trol. The samples were analyzed under nonre-
duced conditions.Hellman et al. BiP-dependent and -independent Protein Folding in the ER 27
ing site algorithm (Blond-Elguindi et al., 1993) was ap-
plied to the lI LC. Peptide scores of between six and 10
were previously shown to be good predictors of peptides
that were able to stimulate the ATPase activity of BiP and
scores of above 10 were considered to be excellent predic-
tors (Knarr et al., 1995). The relevance of a peptide to
stimulate the ATPase activity of BiP is not clear, but it is
generally assumed to indicate the ability of a peptide to
bind BiP (Flynn et al., 1991; Blond Elguindi et al., 1993;
Knarr et al., 1995). Although the variable domain clearly
possesses more peptides with high ÒBiP scores,Ó numerous
peptides scoring above 6 were found in the constant do-
main (Fig. 7). Two peptides had BiP scores of above 10 in
the constant domain compared with four such sequences
in the variable domain. Because we were unable to detect
BiP binding to either an isolated constant domain or the
cysteine-substituted constant domain in vivo, we must con-
clude that either the algorithm is not a good predictor of
BiP-binding sites, or the constant domain folds so rapidly
and stably that BiP does not have the opportunity to inter-
act with it.
Thermal Unfolding of Native and Reduced C Domain
To address these two possibilities, recombinant l LC V
domain and C domain were produced in bacteria, purified,
and then analyzed on reducing SDS gels. The C domain
was relatively pure (Fig. 8 A), but much smaller quantities
of the V domain were obtained and our preparations
continuously had a major contaminating band (data not
shown). The band corresponding to the anticipated size of
the C domain was microsequenced to confirm its identity.
The C domain migrated as a monomer on nonreducing
gels and appeared to have formed the intradomain disul-
fide bond based on its decreased mobility after DTT treat-
ment (Fig. 8 A). The contaminating protein in the V
domain sample prevented us from using it in thermal
unfolding assays, but the C domain was sufficiently pure
for this analysis. The intrinsic fluorescence of a protein
changes as it unfolds. Thus, a proteinÕs stability can be as-
Figure 6. ER-targeted C domain is efficiently secreted and does
not interact with BiP. (A) Cells were transfected with no DNA
(Mock), the ER-targeted constant region gene (ER-Cl), or wild-
type l cDNA along with wild-type hamster BiP. Transfected cells
were labeled for 2 h, culture supernatants were saved, and then
lysates were prepared. The supernatants were precipitated with
anti-l (lm) and the lysates were divided and precipitated with ei-
ther anti-rodent BiP or anti-l. Samples were analyzed on 12%
SDS-gels under reducing conditions. (B) COS-1 cells were
cotransfected with one of the l LC cDNA clones (WTl or ER-
Cl) and either wild-type (WT) or mutant (G37) BiP. Cells were
pulse-labeled as in Fig. 4 and lysed immediately in the presence
of NEM and apyrase. Lysates were divided and immunoprecipi-
tated with anti-mouse l, anti-rodent BiP, or protein AÐSeph-
arose alone. Samples were analyzed on 12% SDS-gels under re-
ducing conditions.
Figure 7. Both the V and C domain of the HOPC 2020 l LC pos-
sess potential BiP-binding sites. The BiP score algorithm was ap-
plied to the amino acid sequence and predicts a value for each
eight amino acids. The value is assigned to the first amino acid of
the octapeptide. Values of between six and 10 are predictive of
possible BiP-binding sites and values above 10 are considered
highly predictive. Negative values identify sequences that are
very unlikely to stimulate the ATPase activity of BiP.The Journal of Cell Biology, Volume 144, 1999 28
sessed by monitoring its fluorescence at increasing tem-
peratures. Thermal unfolding curves were generated for
the C domain in the presence of 10 mM DTT. This was
sufficient to reduce the intradomain disulfide bond, be-
cause the recombinant C domain migrated slower after
DTT treatment (Fig. 8 A). The protein exhibited a single,
cooperative unfolding transition as the temperature in-
creased (Fig. 8 B). The melting temperature (Tm) (i.e., the
temperature at which 50% of the protein is unfolded) of
the C domain under reducing conditions was calculated to
be 50.48C. Interestingly, even after reduction, the C do-
main was still completely folded at 378C and was slightly
more stable than the molecular chaperone BiP (Tm  5
49.28C). This precluded in vitro studies to examine BiP as-
sociation with an unfolded C domain since we were not
able to find conditions where the C domain would be un-
folded and the BiP still functional. Unfortunately it was
not possible to establish a thermal unfolding curve for the
C domain in the absence of DTT, presumably because the
COOH-terminal cysteine, which pairs with a cysteine in
the Ig heavy chain, contributes to aggregate formation un-
der these experimental conditions (data not shown). Thus,
although the exact contribution of the intradomain disul-
fide bond to the stability of the C domain could not be de-
termined, it is clear that the C domain remains remarkably
stable even in the absence of this bond. This may explain
the lack of BiP binding to the C domain in vivo, even when
LCs are synthesized in the presence of reducing agents.
Discussion
The Ig domain is one of the elementary structures that
serve as building blocks for many proteins. Although the
sequences of these domains vary between different pro-
teins, most are composed of seven b strands that fold into
an antiparallel barrel structure that is stabilized by a single
disulfide bond. The data presented here demonstrate that
in spite of the strong structural similarities between Ig do-
mains, the involvement of molecular chaperones in their
folding in vivo can be quite different. All Ig domains that
have been examined thus far possess potential BiP-bind-
ing sites, as detected by a BiP-binding algorithm (Knarr
et al., 1995). It should be stressed that there are currently
no data to demonstrate that any of these sites can be rec-
ognized in an intact protein, nor has an actual in vivo BiP-
binding site been mapped on any protein. As a result,
there is not a consensus in the field as to what is the best
method for identifying potential BiP-binding sites. How-
ever, despite some differences in the sequences identified
by the various hsp70-binding site algorithms, all of them
detect multiple peptides within a given protein that have
the potential to bind an hsp70 family member (Flynn et al.,
1991; Blond-Elguindi et al., 1993; Takenaka et al., 1995;
Rudiger et al., 1997). From the present study, at least in
the case of BiP, it is clear that this does not necessarily
mean they will be used in vivo during the folding of the
protein. Although the NH2-terminal variable domain ex-
amined here is clearly bound to BiP before its complete
folding and oxidation, we were unable to demonstrate BiP
binding to the COOH-terminal constant region domain by
any method. This included both the use of reducing agents
or mutagenesis of cysteine residues to destabilize domain
folding and the expression of BiP ATPase mutants to trap
and stabilize complexes. All of these methods readily al-
lowed us to detect BiP bound to the V domain.
Hsp70 family members interact with substrate proteins
in an ATP-dependent fashion. In vitro experiments have
demonstrated that the ATP-bound form of hsp70 binds
proteins more rapidly than the ADP-bound form, but hy-
drolysis of the bound ATP to ADP is required to stabilize
this binding (Bukau and Horwich, 1998). The G37 BiP
mutant used in this study binds ATP as well as wild-type
BiP, but it is unable to undergo the appropriate conforma-
tion change upon binding to ATP and therefore resembles
the ADP-bound form of BiP (Wei et al., 1995). Thus, it
might be argued that our BiP mutant is less able to com-
plete with endogenous BiP for substrate proteins and
therefore would not act as a kinetic trap for the C domain.
However, the G37 mutant is able to compete well with en-
dogenous wild-type BiP for binding to the V domain of the
LC (this study), the CH1 domain of the Ig heavy chain
(Gaut and Hendershot, 1993), and factor VIII, a compo-
nent of the blood coagulation cascade (Morris et al., 1997).
Nevertheless, it is conceivable that BiP has a much lower
affinity for the C domain and the mutant BiP drops below
a threshold of detectable binding. This would not be a fac-
tor in the experiments where reducing agents or cysteine
mutants were employed. In this case, there was no evi-
dence that either the endogenous BiP or the transfected
wild-type BiP were capable of binding to the unoxidized C
domain. So, at the very least, one must conclude that if BiP
binds to the C domain it must be at a very reduced affinity
Figure 8. The recombinant C domain folds very
stably even in the presence of reducing agents.
(A) Recombinant BiP and C domain of l LC
were isolated and examined for purity and fold-
ing status. The C domain was incubated for 1 h at
378C in the presence (1) or absence of DTT and
then alkylated with a 10-fold molar excess of
NEM. Samples were analyzed by SDS-PAGE
under nonreducing conditions. (B) Thermal de-
naturation curves generated for purified hamster
BiP (h) and for the purified C domain under re-
ducing conditions (s). Fraction of native protein
remaining was calculated at each temperature.Hellman et al. BiP-dependent and -independent Protein Folding in the ER 29
so that mutant BiP can no longer compete, and this bind-
ing must be very transient and not prolonged by prevent-
ing the oxidation of the C domain. Clearly this is in con-
trast to BiPÕs interaction with the V domain.
Our data suggest that it is not the presence of BiP-bind-
ing sites per se that determines whether or not a protein
will associate with BiP. Instead it appears that the folding
pathway and rate at which folding occurs control whether
an individual protein, or region of a protein, will bind to
BiP. If the ÒBiP-bindingÓ sequences are rapidly seques-
tered within the interior of the newly synthesized protein,
they may never be exposed long enough to allow BiP to
bind. The resistance of a portion of newly synthesized C
domain to reducing agents strongly suggests that this do-
main folds rapidly, and the thermal stability of the reduced
C domain demonstrates that it does not require a disulfide
bond to stabilize this folding state. Consistent with this
idea, in vitro folding studies on an isolated human C l do-
main revealed that the conformation of the C domain is
not greatly affected by reducing agents (Goto and Hama-
guchi, 1981).
In spite of the fact that we were readily able to detect
the V domain bound to BiP when it was reduced, we are
not sure how much of the wild-type V domain binds to BiP
when it is produced and folded under physiological condi-
tions. Although clearly some of it can be trapped with the
BiP mutants, we get a much higher proportion binding to
BiP when they are synthesized in the presence of reducing
agents (Hendershot et al., 1996), which destabilizes this
domain. We interpret this to suggest that instead of BiP
playing an active role in folding these proteins, that it may
be standing by to ÒcatchÓ proteins that are either unable
or slow to fold and prevent them from aggregating. Thus,
only proteins that have difficulties in folding or perhaps
multisubunit proteins would require BiP to obtain their
mature conformation. This conclusion is consistent with
data showing that alterations in the levels of wild-type BiP
can change the rate of folding of some proteins (Dorner
et al., 1988; Braakman et al., 1991). Perhaps by greatly in-
creasing the levels of BiP in the ER, low-affinity sites on
proteins that are not normally occupied by BiP would be.
It is interesting to speculate on why these two domains
might have evolved to have different folding stabilities and
chaperone requirements. The variable domains of both Ig
heavy and light chains contain the antigen-binding site and
as such must accommodate a large variety of amino acid
changes to recognize a nearly infinite number of antigens.
Thus, the stability or rate of folding of variable regions
may vary greatly and in some cases require more help to
fold. Recently another LC, the nonsecreted NS-1 k LC,
was shown to bind to BiP via its unfolded V domain
(Skowronek et al., 1998). Unlike the V domains, the con-
stant domains do not contribute directly to the antigen-
binding site and do not vary in sequence within a given iso-
type. The single constant domain of the LC (CL) pairs
with the first constant domain (CH1) of the heavy chain,
which possesses a stable BiP-binding site (Hendershot et
al., 1987). The LC in some as yet undefined way must dis-
place BiP from the heavy chain so Ig assembly can pro-
ceed (Lee, Y.-K., J.W. Brewer, R. Hellman, and L.M.
Hendershot, manuscript submitted for publication). Thus,
the conserved C domain may have evolved to fold rapidly
and stably in order to assist the folding of the CH1 domain.
In support of this role for CL, domain pairing appears to
play a role in the folding of some of the other constant do-
mains of the heavy chain (Kaloff and Haas, 1995).
In conclusion, the studies described here demonstrate
that the two structurally similar Ig domains of the lI LC
behave very differently in respect to their association with
BiP during folding even though both domains possess po-
tential BiP-binding sites. The data suggest that the simple
presence of BiP-binding sites on a nascent chain does not
ensure that BiP will bind and play a role in its folding. In-
stead, our data support a model in which BiP preferen-
tially recognizes proteins that are slower to fold to a stable
conformation.
This work was supported by a grant from the National Institutes of Health
(GM-54068), the Cancer Center CORE (P30 CA21765), and the Ameri-
can Lebanese Syrian Associated Charities of St. Jude ChildrenÕs Research
Hospital.
Received for publication 4 May 1998 and in revised form 9 November
1998.
References
Alberini, C.M., P. Bet, C. Milstein, and R. Sitia. 1990. Secretion of immunoglob-
ulin M assembly intermediates in the presence of reducing agents. Nature.
347:485Ð487.
Amzel, L.M., and R.J. Poljak. 1979. Three-dimensional structure of immuno-
globulins. Annu. Rev. Immunol. 48:961Ð997.
Bernard, O., N. Hozumi, and S. Tonegawa. 1978. Sequences of mouse immuno-
globulin light chain genes before and after somatic changes. Cell. 15:1133Ð
1144.
Blond-Elguindi, S., S.E. Cwirla, W.J. Dower, R.J. Lipshutz, S.R. Sprang, J.F.
Sambrook, and M.J. Gething. 1993. Affinity panning of a library of peptides
displayed on bacteriophages reveals the binding specificity of BiP. Cell. 75:
717Ð728.
Braakman, I., H. Hoover Litty, K.R. Wagner, and A. Helenius. 1991. Folding of
influenza hemagglutinin in the endoplasmic reticulum. J. Cell Biol. 114: 401Ð
411.
Braakman, I., J. Helenius, and A. Helenius. 1992a. Manipulating disulfide bond
formation and protein folding in the endoplasmic reticulum. EMBO (Eur.
Mol. Biol. Organ.) J. 11:1717Ð1722.
Braakman, I., J. Helenius, and A. Helenius. 1992b. Role of ATP and disulphide
bonds during protein folding in the endoplasmic reticulum. Nature. 356:260Ð262.
Bukau, B., and A.L. Horwich. 1998. The Hsp70 and Hsp60 chaperone ma-
chines.  Cell. 92:351Ð366.
Dorner, A.J., M.G. Krane, and R.J. Kaufman. 1988. Reduction of endogenous
GRP78 levels improves secretion of a heterologous protein in CHO cells.
Mol. Cell. Biol. 8:4063Ð4070.
Flynn, G.C., J. Pohl, M.T. Flocco, and J.E. Rothman. 1991. Peptide-binding
specificity of the molecular chaperone BiP. Nature. 353:726Ð730.
Fra, A.M., C. Fagioli, D. Finazzi, R. Sitia, and C.M. Alberini. 1993. Quality con-
trol of ER synthesized proteins: an exposed thiol group as a three-way
switch mediating assembly, retention and degradation. EMBO (Eur. Mol.
Biol. Organ.) J. 12:4755Ð4761.
Gaut, J.R., and L.M. Hendershot. 1993. Mutations within the nucleotide bind-
ing site of immunoglobulin-binding protein inhibit ATPase activity and in-
terfere with release of immunoglobulin heavy chain. J. Biol. Chem. 268:
7248Ð7255.
Gething, M.J., and J. Sambrook. 1992. Protein folding in the cell. Nature. 355:
33Ð45.
Gorlich, D., and T.A. Rapoport. 1993. Protein translocation into proteolipo-
somes reconstituted from purified components of the endoplasmic reticulum
membrane. Cell. 75:615Ð630.
Goto, Y., and K. Hamaguchi. 1981. Formation of the intrachain disulfide bond
in the constant fragment of the immunoglobulin light chain. J. Mol. Biol.
146:321Ð340.
Goto, Y., and K. Hamaguchi. 1982. Unfolding and refolding of the reduced con-
stant fragment of the immunoglobulin light chain. J. Mol. Biol. 156:911Ð926.
Goto, Y., T. Azuma, and K. Hamaguchi. 1979. Refolding of the immunoglobu-
lin light chain. J. Biochem. 85:1427Ð1438.
Graham, K.S., A. Le, and R.N. Sifers. 1990. Accumulation of the insoluble PiZ
variant of human alpha 1-antitrypsin within the hepatic endoplasmic reticu-
lum does not elevate the steady-state level of grp78/BiP. J. Biol. Chem. 265:
20463Ð20468.
Haas, I.G. 1991. BiPÑa heat shock protein involved in immunoglobulin chain
assembly. Curr. Top. Microbiol. Immunol. 167:71Ð82.The Journal of Cell Biology, Volume 144, 1999 30
Hamman, B.D., L.M. Hendershot, and A.E. Johnson. 1998. BiP maintains the
permeability barrier of the ER membrane by sealing the lumenal end of the
translocon pore before and early in translocation. Cell. 92:747Ð758.
Hammond, C., I. Braakman, and A. Helenius. 1994. Role of N-linked oligosac-
charide recognition, glucose trimming, and calnexin in glycoprotein folding
and quality control. Proc. Natl. Acad. Sci. USA. 91:913Ð917.
Hendershot, L., D. Bole, G. Kohler, and J.F. Kearney. 1987. Assembly and se-
cretion of heavy chains that do not associate posttranslationally with immu-
noglobulin heavy chain-binding protein. J. Cell Biol. 104:761Ð767.
Hendershot, L.M., J.-Y. Wei, J.R. Gaut, B. Lawson, P.J. Freiden, and K.G.
Murti. 1995. In vivo expression of mammalian BiP ATPase mutants causes
disruption of the endoplasmic reticulum. Mol. Biol. Cell. 6:283Ð296.
Hendershot, L., J. Wei, J. Gaut, J. Melnick, S. Aviel, and Y. Argon. 1996. Inhi-
bition of immunoglobulin folding and secretion by dominant negative BiP
ATPase mutants. Proc. Natl. Acad. Sci. USA. 93:5269Ð5274.
Hendrick, J.P., and F.U. Hartl. 1993. Molecular chaperone functions of heat-
shock proteins. Annu. Rev. Immunol. 62:349Ð384.
Ho, S.N., H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease. 1989. Site-
directed mutagenesis by overlap extension using the polymerase chain reac-
tion. Gene. 77:51Ð59.
Hurtley, S.M., D.G. Bole, H. Hoover Litty, A. Helenius, and C.S. Copeland.
1989. Interactions of misfolded influenza virus hemagglutinin with binding
protein (BiP). J. Cell Biol. 108:2117Ð2126.
Kaloff, C.R., and I.G. Haas. 1995. Coordination of immunoglobulin chain fold-
ing and immunoglobulin chain assembly is essential for the formation of
functional IgG. Immunity. 2:629Ð637.
Knarr, G., M.J. Gething, S. Modrow, and J. Buchner. 1995. BiP binding se-
quences in antibodies. J. Biol. Chem. 270:27589Ð27594.
Landry, S.J., R. Jordan, R. McMacken, and L.M. Gierasch. 1992. Different con-
formations for the same polypeptide bound to chaperones DnaK and
GroEL.  Nature. 355:455Ð457.
Morris, J.A., A.J. Dorner, C.A. Edwards, L.M. Hendershot, and R.J. Kaufman.
1997. Immunoglobulin binding protein (BiP) function is required to protect
cells from endoplasmic reticulum stress but is not required for the secretion
of selective proteins. J. Biol. Chem. 272:4327Ð4334.
Munro, S., and H.R. Pelham. 1986. An Hsp70-like protein in the ER: identity
with the 78 kd glucose-regulated protein and immunoglobulin heavy chain
binding protein. Cell. 46:291Ð300.
Nicchitta, C.V., and G. Blobel. 1993. Lumenal proteins of the mammalian en-
doplasmic reticulum are required to complete protein translocation. Cell. 73:
989Ð998.
Palleros, D.R., K.L. Reid, L. Shi, W.J. Welch, and A.L. Fink. 1993. ATP-
induced protein-Hsp70 complex dissociation requires K1 but not ATP hy-
drolysis. Nature. 365:664Ð666.
Rudiger, S., L. Germeroth, J. Schneider-Mergener, and B. Bukau. 1997. Sub-
strate specificity of the DnaK chaperone determined by screening cellulose-
bound peptide libraries. EMBO (Eur. Mol. Biol. Organ.) J. 16:1501Ð1507.
Simons, J.F., S. Ferro-Novick, M.D. Rose, and A. Helenius. 1995. BiP/Kar2p
serves as a molecular chaperone during carboxypeptidase Y folding in yeast.
J. Cell Biol. 130:41Ð49.
Skowronek, M.H., L.M. Hendershot, and I.G. Haas. 1998. The variable domain
of non-assembled Ig light chains determines both their half-life and binding
to BiP. Proc. Natl. Acad. Sci. USA. 95:1574Ð1578.
Takenaka, I.M., S.M. Leung, S.J. McAndrew, J.P. Brown, and L.E. Hightower.
1995. Hsc70-binding peptides selected from a phage display peptide library
that resemble organellar targeting sequences. J. Biol. Chem. 270:19839Ð
19844.
Vanhove, M., S. Houba, J. Lamotte-Brasseur, and J.M. Frere. 1995. Probing the
determinants of protein stability: comparison of class A beta-lactamases.
Biochem. J. 308:859Ð864.
Vogel, J.P., L.M. Misra, and M.D. Rose. 1990. Loss of BiP/GRP78 function
blocks translocation of secretory proteins in yeast. J. Cell Biol. 110:1885Ð
1895.
Walter, P., and A.E. Johnson. 1994. Signal sequence recognition and protein
targeting to the endoplasmic reticulum membrane. Annu. Rev. Cell Biol. 10:
87Ð119.
Wei, J.-Y., and L.M. Hendershot. 1995. Characterization of the nucleotide
binding properties and ATPase activity of recombinant hamster BiP purified
from bacteria. J. Biol. Chem. 270:26670Ð26676.
Wei, J.-Y., J.R. Gaut, and L.M. Hendershot. 1995. In vitro dissociation of BiP
peptide complexes requires a conformational change in BiP after ATP bind-
ing but does not require ATP hydrolysis. J. Biol. Chem. 270:26677Ð26682.